Local Support

We are a global leader in the field of rapid diagnostic tests designed to improve the quality of patient care. Specific product lines include tests for rapid and early diagnosis in the fields of cardiovascular, infectious diseases, women's health, drugs of abuse and oncology.

Viewpoints

Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Discover a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.

Products & Services

Cardiometabolic

Our products and services include tests to assist in the diagnosis and management of many cardiometabolic factors and conditions including cardiac markers, glucose and HbA1C, cholesterol levels, blood gases, and home monitoring for VAD and oral anticoagulation.

Toxicology Products & Services

Alere™ Toxicology offers drug testing products and services that are used in a multitude of settings such as hospitals, clinics, physician offices, criminal justice, workplace, rehabilitation, occupational health clinics, and home testing.

IQCP Support Resources

The Clinical Laboratory Improvement Amendments (CLIA) program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing. We are pleased to provide you with materials to support your IQCPs.

Alere Determine™ HIV-1/2 Ag/Ab Combo

Every day counts – now you can help identify HIV just days after infection. The Alere Determine™ HIV Combo empowers you at the point-of-care, to diagnose HIV earlier than ever before. The Alere Determine™ HIV 1/2 Ag/Ab Combo gives you a new advantage in the fight against AIDS- the ability to identify HIV sooner than conventional rapid tests, which rely solely on the presence of HIV 1/2 antibodies.

The Alere Determine™ HIV 1/2 Ag/Ab Combo is the first rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 antigen, which can appear just 12-26 days after infection¹,² HIV-1/2 antibodies first appear significantly later – 20 – 45 days after infection. By detecting HIV earlier, you are helping to prevent further transmission during this extremely infectious stage.

Empowering

Dependable

It provides clear results in just 20 minutes, with built-in quality controls to let you know the test is working.

Efficient

It requires minimal training and no expensive laboratory equipment.

Flexible

It’s designed for fingerstick testing of whole blood, as well as serum or plasma samples.

Alere Determine™ HIV-1/2 Ag/Ab Combo gives you a new advantage in the fight against AIDS – the ability to detect HIV sooner than conventional rapid tests, which rely solely on the presence of HIV-1/2 antibodies.6, 7
Click image for full size view.

By detecting HIV earlier, you are helping to prevent further transmission during this extremely infectious early stage.